MCRA has several partners we work with and recommend as it relates to assisting companies with successful commercialization strategies both pre- and post-commercialization for medical device, biologic, and combination products. These include but are not limited to consulting firms, biostatisticians, and pre-clinical testing labs. Please find below representative companies that we work closely with.
The Bruder Consulting & Venture Group (BCVG) is focused on helping sponsors identify, develop, commercialize, partner and acquire biologic-based product solutions in othopaedics, spine, sports medicine, wound care and plastic surgery. Led by industry veteran Scott Bruder, MD, PhD, his team of scientists, clinicians and seasoned business professionals boast over 300 years of direct experience in areas that complement the strengths of MCRA.
Medical Metrics Inc. (MMI) is an experienced provider of medical imaging core laboratory services for multicenter clinical trials. MMI's ISO 9001-certified services include imaging protocol development, medical image management, independent image review, and scientific consulting. With 20+ years of experience on hundreds of studies, MMI can support global trials ranging from early-phase feasibility to post-market surveillance across a range of therapeutic areas, including orthopedics, spine, neurology, cardiology, vascular and surgical interventions, ENT, and AI/ML technologies.
Tissue Analytics is a pioneering developer of automated mobile wound and skin imaging and predictive analytics solutions. The company’s flagship product allows patients to download a secure app to their smartphone that the patient can use to send in pictures of their wound, as well as critical data like the degree of pain and itching during wound dressing changes. Images and data are sent securely to the provider’s dashboard, where the system automatically traces the wound, measures and maps the wound, and provides key metrics to the database.